We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Bank First Corp
BFC
$1.7B
| $2.65M | ﹤0.01% |
34,653
+348
| +1% | +$27.1K |
|
2227
Energy Fuels
UUUU
$3.53B
| $2.65M | ﹤0.01% |
432,413
-139,840
| -24% | -$894K |
|
|
PLYM
2228
DELISTED
Plymouth Industrial REIT
PLYM
| $2.65M | ﹤0.01% |
157,369
-85,700
| -35% | -$1.66M |
|
2229
Butterfly Network
BFLY
$2.35B
| $2.64M | ﹤0.01% |
561,639
-20,052
| -3% | -$106K |
|
2230
CNA Financial
CNA
$14.1B
| $2.64M | ﹤0.01% |
71,461
-6,818
| -9% | -$278K |
|
|
FRG
2231
DELISTED
Franchise Group, Inc.
FRG
| $2.63M | ﹤0.01% |
108,291
-3,113
| -3% | -$102K |
|
2232
Sana Biotechnology
SANA
$980M
| $2.63M | ﹤0.01% |
437,607
-167,900
| -28% | -$1.21M |
|
2233
Napco Security Technologies
NSSC
$1.48B
| $2.62M | ﹤0.01% |
90,226
+8,627
| +11% | +$230K |
|
|
SHOE
2234
Shoe Station Group
SHOE
$428M
| $2.62M | ﹤0.01% |
122,320
-946
| -0.8% | -$21.7K |
|
2235
Levi Strauss
LEVI
$9.39B
| $2.62M | ﹤0.01% |
181,082
-6,819
| -4% | -$122K |
|
|
EGLE
2236
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $2.61M | ﹤0.01% |
60,407
+693
| +1% | +$32.8K |
|
|
AMWD
2237
DELISTED
American Woodmark
AMWD
| $2.61M | ﹤0.01% |
59,444
-1,264
| -2% | -$61.6K |
|
2238
Astec Industries
ASTE
$1.02B
| $2.6M | ﹤0.01% |
83,334
-1,606
| -2% | -$65.3K |
|
|
INFN
2239
DELISTED
Infinera Corporation Common Stock
INFN
| $2.6M | ﹤0.01% |
536,707
-4,479
| -0.8% | -$24.6K |
|
2240
PDF Solutions
PDFS
$2.07B
| $2.58M | ﹤0.01% |
105,238
-4,157
| -4% | -$105K |
|
2241
BioXcel Therapeutics
BTAI
$27.8M
| $2.57M | ﹤0.01% |
13,602
+6,645
| +96% | +$1.54M |
|
2242
Apogee Enterprises
APOG
$908M
| $2.57M | ﹤0.01% |
67,283
-1,569
| -2% | -$63.9K |
|
2243
Peoples Bancorp
PEBO
$1.47B
| $2.56M | ﹤0.01% |
88,509
-2,978
| -3% | -$87.6K |
|
2244
Yext
YEXT
$574M
| $2.56M | ﹤0.01% |
573,780
-16,057
| -3% | -$74.5K |
|
2245
Alto Ingredients
ALTO
$340M
| $2.56M | ﹤0.01% |
701,951
-1,173,255
| -63% | -$4.94M |
|
2246
MaxCyte
MXCT
$126M
| $2.55M | ﹤0.01% |
392,856
-7,375
| -2% | -$41.1K |
|
|
ME
2247
DELISTED
23andMe Holding Co
ME
| $2.55M | ﹤0.01% |
44,538
+7,212
| +19% | +$472K |
|
|
ZEUS
2248
DELISTED
Olympic Steel
ZEUS
| $2.54M | ﹤0.01% |
111,433
-21,160
| -16% | -$571K |
|
2249
Playtika
PLTK
$1.12B
| $2.54M | ﹤0.01% |
269,989
-5,400
| -2% | -$62.2K |
|
|
POSH
2250
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
| $2.53M | ﹤0.01% |
161,586
-2,125
| -1% | -$25.3K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.